Difficulty: Medium
Average Score: 67%
Practice
The drug of choice in the treatment of petit mal (absence seizures) is:
Correct answer
B
Rationale
In the treatment of petit mal (absence seizures), the drug of choice is Ethosuximide (Option B). Ethosuximide specifically targets and controls absence seizures by blocking T-type calcium channels in the thalamic neurons, which are implicated in the generation of these types of seizures. This mechanism of action makes it more effective for petit mal seizures compared to the other options.
Phenytoin (Option A) is more commonly used for tonic-clonic and focal seizures, not absence seizures. Phenobarbital (Option C) is more effective for generalized tonic-clonic and partial seizures, not absence seizures. Carbamazepine (Option D) is primarily used for focal seizures and trigeminal neuralgia, not absence seizures.
In an educational context, understanding the specific mechanisms of action and indications for each anti-seizure medication is crucial for pharmacology students and healthcare professionals to make informed decisions when selecting the appropriate drug for a patient's condition. This knowledge ensures safe and effective treatment interventions, highlighting the importance of accurate drug selection based on the type of seizure disorder being treated.
Phenytoin (Option A) is more commonly used for tonic-clonic and focal seizures, not absence seizures. Phenobarbital (Option C) is more effective for generalized tonic-clonic and partial seizures, not absence seizures. Carbamazepine (Option D) is primarily used for focal seizures and trigeminal neuralgia, not absence seizures.
In an educational context, understanding the specific mechanisms of action and indications for each anti-seizure medication is crucial for pharmacology students and healthcare professionals to make informed decisions when selecting the appropriate drug for a patient's condition. This knowledge ensures safe and effective treatment interventions, highlighting the importance of accurate drug selection based on the type of seizure disorder being treated.